» Articles » PMID: 30294904

Bone Marrow Mesenchymal Stem Cells Stimulated with Low-intensity Pulsed Ultrasound: Better Choice of Transplantation Treatment for Spinal Cord Injury: Treatment for SCI by LIPUS-BMSCs Transplantation

Overview
Specialties Neurology
Pharmacology
Date 2018 Oct 9
PMID 30294904
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Stem cell transplantation, especially treatment with bone marrow mesenchymal stem cells (BMSCs), has been considered a promising therapy for the locomotor and neurological recovery of spinal cord injury (SCI) patients. However, the clinical benefits of BMSCs transplantation remain limited because of the considerably low viability and inhibitory microenvironment. In our research, low-intensity pulsed ultrasound (LIPUS), which has been widely applied to clinical applications and fundamental research, was employed to improve the properties of BMSCs. The most suitable intensity of LIPUS stimulation was determined. Furthermore, the optimized BMSCs were transplanted into the epicenter of injured spinal cord in rats, which were randomized into four groups: (a) Sham group (n = 10), rats received laminectomy only and the spinal cord remained intact. (b) Injury group (n = 10), rats with contused spinal cord subjected to the microinjection of PBS solution. (c) BMSCs transplantation group (n = 10), rats with contused spinal cord were injected with BMSCs without any priming. (d) LIPUS-BMSCs transplantation group (n = 10), BMSCs stimulated with LIPUS were injected at the injured epicenter after contusion. Rats were then subjected to behavioral tests, immunohistochemistry, and histological observation. It was found that BMSCs stimulated with LIPUS obtained higher cell viability, migration, and neurotrophic factors expression in vitro. The rate of apoptosis remained constant. After transplantation of BMSCs and LIPUS-BMSCs postinjury, locomotor function was significantly improved in LIPUS-BMSCs transplantation group with higher level of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the epicenter, and the expression of neurotrophic receptor was also enhanced. Histological observation demonstrated reduced cavity formation in LIPUS-BMSCs transplantation group when comparing with other groups. The results suggested LIPUS can improve BMSCs viability and neurotrophic factors expression in vitro, and transplantation of LIPUS-BMSCs could promote better functional recovery, indicating possible clinical application for the treatment of SCI.

Citing Articles

Low-intensity pulsed ultrasound promotes proliferation and differentiation of neural stem cells to enhance spinal cord injury recovery.

Liao Y, Tian M, Zhou W, He B, Tang C, Tang Q Mol Biol Rep. 2025; 52(1):245.

PMID: 39964570 DOI: 10.1007/s11033-025-10333-5.


Acoustic vibration promotes in vitro expansion of human embryonic stem cells.

Hu X, Duan H, Zou D, Dong C, Wang Y, Wang Y Am J Stem Cells. 2024; 13(3):143-151.

PMID: 39021373 PMC: 11249672. DOI: 10.62347/PJFC2708.


Preconditioning of MSCs for Acute Neurological Conditions: From Cellular to Functional Impact-A Systematic Review.

Serrenho I, Ferreira S, Baltazar G Cells. 2024; 13(10.

PMID: 38786067 PMC: 11119364. DOI: 10.3390/cells13100845.


Ultrasound-triggered three dimensional hyaluronic acid hydrogel promotes in vitro and in vivo reprogramming into induced pluripotent stem cells.

Kim D, Lee M, Arai Y, Ahn J, Lee G, Lee S Bioact Mater. 2024; 38:331-345.

PMID: 38764447 PMC: 11101682. DOI: 10.1016/j.bioactmat.2024.05.011.


Sonomechanobiology: Vibrational stimulation of cells and its therapeutic implications.

Ambattu L, Yeo L Biophys Rev (Melville). 2024; 4(2):021301.

PMID: 38504927 PMC: 10903386. DOI: 10.1063/5.0127122.


References
1.
Zhao T, Yan W, Xu K, Qi Y, Dai X, Shi Z . Combined treatment with platelet-rich plasma and brain-derived neurotrophic factor-overexpressing bone marrow stromal cells supports axonal remyelination in a rat spinal cord hemi-section model. Cytotherapy. 2013; 15(7):792-804. DOI: 10.1016/j.jcyt.2013.04.004. View

2.
Garbossa D, Boido M, Fontanella M, Fronda C, Ducati A, Vercelli A . Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells. Neurosurg Rev. 2012; 35(3):293-311. DOI: 10.1007/s10143-012-0385-2. View

3.
Manley N, Priest C, Denham J, Wirth 3rd E, Lebkowski J . Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury. Stem Cells Transl Med. 2017; 6(10):1917-1929. PMC: 6430160. DOI: 10.1002/sctm.17-0065. View

4.
Salem K, Schmelz A . Low-intensity pulsed ultrasound shortens the treatment time in tibial distraction osteogenesis. Int Orthop. 2014; 38(7):1477-82. PMC: 4071501. DOI: 10.1007/s00264-013-2254-1. View

5.
Ishikawa C, Senba M, Mori N . Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma. Int J Oncol. 2017; 51(2):633-643. DOI: 10.3892/ijo.2017.4026. View